Michael T Sember - Net Worth and Insider Trading

Michael T Sember Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael T Sember owns 2 companies in total, including Soligenix Inc (SNGX) , and Quoin Pharmaceuticals Ltd (QNRX) .

Click here to see the complete history of Michael T Sember’s form 4 insider trades.

Insider Ownership Summary of Michael T Sember

Ticker Comapny Transaction Date Type of Owner
SNGX Soligenix Inc 2004-12-07 director & Chief Executive Officer
QNRX Quoin Pharmaceuticals Ltd 2023-01-01 director

Michael T Sember Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael T Sember Ownership Network

Ownership Network List of Michael T Sember

No Data

Ownership Network Relation of Michael T Sember

Insider Network Chart

Michael T Sember Owned Company Details

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Michael T Sember is the director & Chief Executive Officer of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Soligenix Inc Insider Transactions

No Available Data

Michael T Sember Mailing Address

Above is the net worth, insider trading, and ownership report for Michael T Sember. You might contact Michael T Sember via mailing address: Azrieli Center, Round Tower, 30th Floor, Tel Aviv L3 671101.

Discussions on Michael T Sember

No discussions yet.